Request for TOC Request for Sample
BUY NOW

Global Home Medical Equipment Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Healthcare | Upcoming Report | Mar 2025 | Global | 350 Pages | No of Tables: 220 | No of Figures: 60
Nucleus

Circumvent the Tariff challenges with an agile supply chain Consulting

Supply Chain Ecosystem Analysis now part of DBMR Reports

Global Home Medical Equipment Market

Market Size in USD Billion

CAGR :  %

USD 28.17 Billion USD 43.23 Billion 2024 2032
Forecast Period
2025 –2032
Market Size(Base Year)
USD 28.17 Billion
Market Size (Forecast Year)
USD 43.23 Billion
CAGR
%
Major Markets Players
  • Abbott (U.S.)
  • ARKRAY
  • Inc. (Japan)
  • Baxter (U.S.)
  • B. Braun Melsungen AG (Germany)

Global Home Medical Equipment Market Segmentation, By Functionality (Therapeutic Equipment, Patient Monitoring Equipment, Mobility Assist, and Patient Support Equipment), Distribution Channel (Pharmacies, Retail Medical Stores, and Online Retailers), End Users (Hospitals, Home Care Settings, and Others) – Industry Trends and Forecast to 2032

 

Global Home Medical Equipment Market Analysis

The global home medical equipment market is experiencing significant growth, driven by several key factors. The increasing prevalence of chronic diseases, such as diabetes and respiratory disorders, is a major contributor to the rising demand for home-based medical devices. In addition, the aging population worldwide is leading to a greater need for home healthcare solutions that support autonomy and improve quality of life. Innovations in home medical equipment, including the integration of smart technology and telehealth services, are enhancing patient care and ease of use, further stimulating market expansion. The COVID-19 pandemic has also accelerated the shift towards home-based healthcare, with patients opting for home care to reduce exposure to the virus and alleviate the burden on hospitals. Favorable reimbursement structures and governmental efforts advocating for home healthcare services are supporting this trend, ensuring patients have access to essential medical equipment within their residences. Overall, the dynamic environment created by these factors is conducive to ongoing growth within the home medical equipment sector.

Global Home Medical Equipment Market Size

The global home medical equipment market size was valued at USD 28.17 billion in 2024 and is projected to reach USD 43.23 billion by 2032, with a CAGR of 5.50% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global Home Medical Equipment Market Trends

“Increasing Prevalence of Chronic Diseases”

The increasing prevalence of chronic diseases, such as diabetes, cardiovascular conditions, and respiratory ailments, is significantly driving the demand for home medical equipment. As the incidence of these chronic conditions continues to rise, patients are seeking convenient and efficient ways to manage their health from the comfort of their homes. Home medical equipment, including blood glucose monitors, blood pressure cuffs, and respiratory devices, enables patients to track and manage their health parameters effectively, reducing the need for frequent hospital visits. Moreover, the integration of smart technology and remote monitoring capabilities in these devices allows for real-time health data collection and communication with healthcare providers. This ensures timely interventions and personalized treatment plans, ultimately improving patient outcomes. The convenience and accessibility of home medical equipment empower patients to take a proactive role in their health management, leading to better adherence to treatment regimens and enhanced quality of life. In addition, home-based care is a cost-effective solution that alleviates the burden on healthcare facilities, making it an attractive option for both patients and healthcare systems. As chronic diseases become more prevalent, the demand for home medical equipment is expected to continue growing, revolutionizing the way healthcare is delivered.

Report Scope and Home Medical Equipment Market Segmentation  

Attributes

 Global Home Medical Equipment Market Insights

Segments Covered

  • By Functionality: Therapeutic Equipment, Patient Monitoring Equipment, and Mobility Assist and Patient Support Equipment
  • By Distribution Channel: Pharmacies, Retail Medical Stores, and Online Retailers
  • End-User: Hospitals, Home Care Settings, and Others

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Key Market Players

Abbott (U.S.), ARKRAY, Inc. (Japan), Baxter (U.S.), B. Braun Melsungen AG (Germany), ConvaTec Inc. (U.K.), The Cooper Companies Inc. (U.S.), DeVilbiss Healthcare LLC (U.S.), Medical Depot, Inc. (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), General Electric (U.S.), GF Health Products, Inc. (U.S.), Hill-Rom Services, Inc. (U.S.), Invacare Corporation (U.S.), Johnson & Johnson Services, Inc. (U.S.), BD (Becton, Dickinson and Company) (U.S.), Medtronic (Ireland), Smith+Nephew (U.K.), OMRON Corporation (Japan), ResMed (Australia), and Smiths Group plc (U.K.)

Market Opportunities

  •  Expansion in Emerging Markets 
  • Strategic Partnerships Driving Growth in Medical Device Industry

Value Added Data Infosets

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global Home Medical Equipment Market Definition

Home medical equipment refers to a wide range of medical devices and products used by patients in their homes to manage and monitor various health conditions. These devices are designed to provide patients with the necessary tools to maintain their health, manage chronic illnesses, and recover from surgeries or injuries in a comfortable and familiar environment. Home medical equipment includes items such as mobility aids (wheelchairs, walkers), respiratory therapy devices (oxygen concentrators, nebulizers), monitoring devices (blood pressure monitors, glucose meters), and therapeutic products (hospital beds, infusion pumps).

Global Home Medical Equipment Market Dynamics

Drivers

  • Increased Healthcare Expenditure 

Rising healthcare expenditure, particularly in developed regions like North America, is significantly fueling the demand for home medical equipment. This increase in spending is driven by a variety of factors, including the growing prevalence of chronic diseases, an aging population, and advances in medical technology. As healthcare costs continue to escalate, there is a stronger emphasis on cost-effective solutions that can be implemented in home settings. Home medical equipment offers a practical alternative to frequent hospital visits, reducing overall healthcare expenses while providing patients with the convenience and comfort of managing their health at home. Additionally, government initiatives and healthcare policies in developed countries are increasingly supportive of home-based care, further encouraging the adoption of home medical devices. The increased investment in healthcare infrastructure and the rising awareness about the benefits of home medical equipment are also contributing to this trend. As a result, more patients and healthcare providers are turning to home medical equipment as a reliable and efficient means of delivering quality care, driving market growth and innovation in this sector. This shift towards home healthcare is expected to continue, further expanding the demand for home medical equipment in the coming years.

  • Shift Towards Home-Based Care 

The shift towards home-based care over hospital stays is gaining momentum, driven by the dual need for cost-effective healthcare solutions and the desire for personalized care. Home-based care allows patients to receive medical attention in the comfort of their own homes, reducing the financial burden associated with prolonged hospital stays and minimizing the risk of hospital-acquired infections. This approach not only offers a more convenient and comfortable environment for patients but also provides a more personalized level of care tailored to individual needs. Advances in medical technology, such as remote monitoring and telemedicine, have further facilitated this shift by enabling healthcare providers to deliver high-quality care and monitor patients' health status remotely. Home medical equipment, such as portable oxygen concentrators, infusion pumps, and mobility aids, plays a crucial role in supporting this trend, empowering patients to manage their conditions effectively at home. The preference for home-based care is particularly pronounced among the elderly and those with chronic illnesses, who benefit from the enhanced sense of independence and improved quality of life that home-based care provides. As healthcare systems continue to evolve, the shift towards home-based care is expected to accelerate, transforming the way healthcare services are delivered.

Opportunities

  • Expansion in Emerging Markets 

Developing regions such as Asia-Pacific, Latin America, and the Middle East & Africa present substantial growth opportunities for the home medical equipment market due to the increasing healthcare infrastructure and rising awareness about the benefits of home-based care. These regions are witnessing rapid advancements in their healthcare systems, driven by government initiatives, foreign investments, and the growing need to address the healthcare demands of their expanding populations. As awareness of chronic diseases and their management continues to rise, there is a growing demand for home medical equipment that allows patients to monitor and manage their health conditions conveniently at home. In addition, the increasing adoption of telemedicine and remote patient monitoring in these regions is further fueling the demand for home medical devices. The affordability and accessibility of home medical equipment make it an attractive option for patients seeking cost-effective healthcare solutions. Furthermore, the presence of a large and untapped market in these developing regions provides significant growth potential for manufacturers and distributors of home medical equipment. As these markets continue to develop and mature, the home medical equipment industry is expected to experience substantial growth, offering improved healthcare outcomes and enhanced quality of life for patients across these regions.

  • Strategic Partnerships Driving Growth in Medical Device Industry

In the competitive landscape of the medical device industry, strategic partnerships and collaborations between manufacturers and healthcare providers are proving to be a powerful catalyst for market growth. These alliances are not only enhancing the breadth and depth of product offerings but are also significantly improving distribution networks. By partnering with healthcare providers, medical device manufacturers can leverage clinical insights and expertise to innovate and refine their products, ensuring they meet the specific needs of medical professionals and patients. In addition, these collaborations facilitate faster and more efficient distribution of medical devices, as healthcare providers often have established networks and relationships within the medical community. This synergistic approach helps in overcoming market entry barriers, expanding market reach, and ultimately driving sales and revenue growth. Furthermore, collaborations often lead to joint research and development initiatives, resulting in cutting-edge technologies and advanced medical solutions that improve patient outcomes. In an era where healthcare demands are rapidly evolving, these strategic partnerships are essential for staying competitive and responsive to market needs. As a result, companies that prioritize and invest in building robust collaborations with healthcare providers are well-positioned to thrive and lead in the dynamic medical device market.

Restraints/Challenges

  • High Cost of Home Medical Equipment

The high costs associated with home medical equipment are a significant barrier to its widespread adoption. Many devices, such as ventilators, oxygen concentrators, and specialized beds, require a substantial initial investment that can be prohibitive for patients and their families. In addition, the need for ongoing maintenance, servicing, and occasional replacements further adds to the financial burden. These high costs are particularly challenging for those without adequate insurance coverage or access to financial assistance programs. Consequently, patients in lower-income brackets or those residing in regions with limited healthcare funding may struggle to afford essential home medical equipment. This lack of affordability can result in compromised health outcomes, as patients may forgo necessary devices or resort to suboptimal alternatives.

  • Delaying Innovations in the Medical Device Market

One of the primary challenges faced by the home medical equipment market is navigating stringent regulations and lengthy approval processes for new devices. Regulatory bodies, such as the FDA in the United States and the EMA in Europe, have established rigorous standards to ensure the safety and efficacy of medical devices. While these regulations are crucial for patient protection, they can also create significant delays in bringing innovative products to market. The comprehensive evaluation process involves extensive clinical trials, meticulous documentation, and thorough inspections, which can take several years to complete. These delays not only increase the time to market but also elevate the costs associated with research and development. As a result, manufacturers may be hesitant to invest in new technologies, slowing the pace of innovation. Furthermore, the complexity and variability of regulatory requirements across different regions add another layer of challenge for companies operating on a global scale.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Home Medical Equipment Market Scope

The market is segmented on the basis by functionality, distribution channel, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Functionality

  • Therapeutic Equipment
  • Patient Monitoring Equipment
  • Mobility Assist and Patient Support Equipment

Distribution Channel

  • Pharmacies
  • Retail Medical Stores
  • Online Retailers

End User

  • Hospitals
  • Home Care Settings
  • Others

Global Home Medical Equipment Market Analysis

The market is analysed and market size insights and trends are provided by country, by functionality, by distribution channel and by end user as referenced above.

The countries covered in the market report are U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Rest of South America as a part of South America, U.A.E, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America region is expected to the dominate the market for home medical equipment market. The region's well-established healthcare infrastructure, coupled with high healthcare expenditure, has facilitated the widespread adoption of advanced home medical equipment. In addition, the presence of major market players and continuous technological advancements contribute to the region's leadership position. The aging population in North America, particularly in the U.S. and Canada, has led to an increased demand for home-based healthcare solutions, further propelling market growth. Moreover, favourable reimbursement policies and government initiatives aimed at promoting home healthcare have played a crucial role in boosting the market.

Asia Pacific region is the fastest-growing market for home medical equipment market. This rapid growth can be attributed to several factors, including the increasing prevalence of chronic diseases, a growing aging population, and rising healthcare awareness among consumers. In addition, the region is witnessing significant economic development, which is leading to improved healthcare infrastructure and increased disposable income. Countries like China, India, and Japan are at the forefront of this growth, with substantial investments in healthcare technology and home-based medical solutions. The adoption of advanced medical devices and the expansion of telehealth services are further driving the demand for home medical equipment in the Asia-Pacific region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Global Home Medical Equipment Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Global Home Medical Equipment Operating in the Market Are:

  • Abbott (U.S.)
  • ARKRAY, Inc. (Japan)
  • Baxter (U.S.)
  • B. Braun Melsungen AG (Germany)
  • ConvaTec Inc. (U.K.)
  • The Cooper Companies Inc. (U.S.)
  • DeVilbiss Healthcare LLC (U.S.)
  • Medical Depot, Inc. (U.S.)
  • Fresenius Medical Care AG & Co. KGaA (Germany)
  • General Electric (U.S.)
  • GF HEALTH PRODUCTS, INC. (U.S.)
  • Hill-Rom Services, Inc. (U.S.)
  • Invacare Corporation (U.S.)
  • Johnson & Johnson Services, Inc. (U.S.)
  • BD (Becton, Dickinson and Company) (U.S.)
  • Medtronic (Ireland)
  • Smith+Nephew (U.K.)
  • OMRON Corporation (Japan)
  • ResMed (Australia)
  • Smiths Group plc (U.K.)

Latest Developments in Home Medical Equipment Market 

  • In December 2022, Mindray unveiled their latest innovation, the 'mWear System,' a wearable monitoring solution designed to continuously track patient conditions and prioritize patient-centric care. This system features complete wireless connectivity, streamlined workflows for enhanced efficiency, precise multi-parameter monitoring, and seamless integration for use in both home and hospital settings
  • In July 2022, B. Braun Medical Inc. introduced the Introcan Safety 2 IV Catheter, featuring one-time blood control to enhance IV access safety for clinicians. This innovative catheter aims to reduce the risk of needlestick injuries and minimize clinicians' exposure to blood, thereby improving overall safety during medical procedures


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL HOME MEDICAL EQUIPMENT MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 KEY TAKEAWAYS

2.2 ARRIVING AT THE GLOBAL HOME MEDICAL EQUIPMENT MARKET SIZE

2.2.1 VENDOR POSITIONING GRID

2.2.2 TECHNOLOGY LIFE LINE CURVE

2.2.3 MARKET GUIDE

2.2.4 COMPANY POSITIONING GRID

2.2.5 COMPANY MARKET SHARE ANALYSIS

2.2.6 MULTIVARIATE MODELLING

2.2.7 TOP TO BOTTOM ANALYSIS

2.2.8 STANDARDS OF MEASUREMENT

2.2.9 VENDOR SHARE ANALYSIS

2.2.10 SALES VOLUME DATA

2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS

2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES

2.3 GLOBAL HOME MEDICAL EQUIPMENT MARKET: RESEARCH SNAPSHOT

2.4 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 CHALLENGES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

5.1 PORTER’S 5 FORCES

5.2 PESTLE ANALYSIS

6 EPIDEMIOLOGY

6.1 PREVALENCE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY COUNTRY

6.2 PREVALENCE OF SENSORINEURAL HEARING LOSS, BY COUNTRY

6.3 PREVALENCE OF CONDUCTIVE HEARING LOSS, BY COUNTRY

6.4 PREVALENCE OF DIABETES, BY COUNTRY

6.5 PREVALENCE OF HYPERTENSION, BY COUNTRY

6.6 PREVALENCE OF OBESITY, BY COUNTRY

6.7 PREVALENCE BONE AND JOINT DISEASES, BY AGE GROUP

6.8 INCIDENCE AND PREVALANCE OF ALZHEIMER’S DISEASE, BY COUNTRY

6.9 INCIDENCE AND PREVALENCE OF CARDIOVASCULAR DISEASE, BY COUNTRY

6.1 INCIDENCE AND PREVALANCE OF PARKINSON’S DISEASE, BY COUNTRY

6.11 INCIDENCE OF TRAUMA WOUNDS, BY COUNTRY

6.12 INCIDENCE OF DIABETIC FOOT ULCERS, BY COUNTRY

6.13 INCIDENCE OF VENOUS ULCERS, BY COUNTRY

6.14 INCIDENCE OF PRESSURE ULCERS, BY COUNTRY

7 INDUSTRY INSIGHTS

7.1 DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES

7.2 PATIENT FLOW DIAGRAM

7.3 KEY PRICING STRATEGIES

7.4 KEY PATIENT ENROLLMENT STRATEGIES

7.5 INTERVIEWS WITH GENERAL PHYSICIAN

7.6 OTHER KOL SNAPSHOTS

8 REGULATORY SCENARIO

9 GLOBAL HOME MEDICAL EQUIPMENT MARKET, BY PRODUCT TYPE

9.1 (NOTE: MARKET VALUE, VOLUME AND ASP WILL BE PROVIDED FOR ALL SEGMENTS AND SUB-SEGMENTS)

9.2 OVERVIEW

9.3 TESTING, SCREENING, AND MONITORING

9.3.1 BLOOD PRESSURE MONITORS

9.3.1.1. SPHYGMOMANOMETER/ANEROID BP MONITOR

9.3.1.1.1. MARKET VALUE (USD MILLION)

9.3.1.1.2. MARKET VOLUME (UNITS)

9.3.1.1.3. AVERAGE SELLING PRICE (USD)

9.3.1.2. AUTOMATED/DIGITAL BLOOD PRESSURE MONITOR

9.3.1.2.1. ARM

9.3.1.2.1.1 MARKET VALUE (USD MILLION)

9.3.1.2.1.2 MARKET VOLUME (UNITS)

9.3.1.2.1.3 AVERAGE SELLING PRICE (USD)

9.3.1.2.2. WRIST

9.3.1.2.2.1 MARKET VALUE (USD MILLION)

9.3.1.2.2.2 MARKET VOLUME (UNITS)

9.3.1.2.2.3 AVERAGE SELLING PRICE (USD)

9.3.1.2.3. FINGER

9.3.1.2.3.1 MARKET VALUE (USD MILLION)

9.3.1.2.3.2 MARKET VOLUME (UNITS)

9.3.1.2.3.3 AVERAGE SELLING PRICE (USD)

9.3.1.3. AMBULATORY BLOOD PRESSURE MONITOR

9.3.1.3.1. MARKET VALUE (USD MILLION)

9.3.1.3.2. MARKET VOLUME (UNITS)

9.3.1.3.3. AVERAGE SELLING PRICE (USD)

9.3.1.4. BLOOD PRESSURE CUFFS

9.3.1.4.1. DISPOSABLE

9.3.1.4.1.1 MARKET VALUE (USD MILLION)

9.3.1.4.1.2 MARKET VOLUME (UNITS)

9.3.1.4.1.3 AVERAGE SELLING PRICE (USD)

9.3.1.4.2. REUSABLE

9.3.1.4.2.1 MARKET VALUE (USD MILLION)

9.3.1.4.2.2 MARKET VOLUME (UNITS)

9.3.1.4.2.3 AVERAGE SELLING PRICE (USD)

9.3.1.4.3. OTHERS

9.3.2 BLOOD GLUCOSE MONITORS

9.3.2.1. CONTINUOUS GLUCOSE MONITOR (CGM)

9.3.2.1.1. MARKET VALUE (USD MILLION)

9.3.2.1.2. MARKET VOLUME (UNITS)

9.3.2.1.3. AVERAGE SELLING PRICE (USD)

9.3.2.2. SELF-MONITORING SYSTEMS

9.3.2.2.1. BLOOD GLUCOSE METERS

9.3.2.2.1.1 MARKET VALUE (USD MILLION)

9.3.2.2.1.2 MARKET VOLUME (UNITS)

9.3.2.2.1.3 AVERAGE SELLING PRICE (USD)

9.3.2.2.2. TESTING STRIPS

9.3.2.2.2.1 MARKET VALUE (USD MILLION)

9.3.2.2.2.2 MARKET VOLUME (UNITS)

9.3.2.2.2.3 AVERAGE SELLING PRICE (USD)

9.3.2.2.3. LANCETS & LANCING DEVICES

9.3.2.2.3.1 MARKET VALUE (USD MILLION)

9.3.2.2.3.2 MARKET VOLUME (UNITS)

9.3.2.2.3.3 AVERAGE SELLING PRICE (USD)

9.3.3 PULSE OXIMETERS

9.3.3.1. PORTABLE PULSE OXIMETER

9.3.3.1.1. FINGERTIP PULSE OXIMETER

9.3.3.1.1.1 MARKET VALUE (USD MILLION)

9.3.3.1.1.2 MARKET VOLUME (UNITS)

9.3.3.1.1.3 AVERAGE SELLING PRICE (USD)

9.3.3.1.2. HANDHELD PULSE OXIMETER

9.3.3.1.2.1 MARKET VALUE (USD MILLION)

9.3.3.1.2.2 MARKET VOLUME (UNITS)

9.3.3.1.2.3 AVERAGE SELLING PRICE (USD)

9.3.3.2. WEARABLE PULSE OXIMETER

9.3.3.2.1. WRIST-WORN

9.3.3.2.1.1 MARKET VALUE (USD MILLION)

9.3.3.2.1.2 MARKET VOLUME (UNITS)

9.3.3.2.1.3 AVERAGE SELLING PRICE (USD)

9.3.3.2.2. EARLOBE

9.3.3.2.2.1 MARKET VALUE (USD MILLION)

9.3.3.2.2.2 MARKET VOLUME (UNITS)

9.3.3.2.2.3 AVERAGE SELLING PRICE (USD)

9.3.3.2.3. FOREHEAD

9.3.3.2.3.1 MARKET VALUE (USD MILLION)

9.3.3.2.3.2 MARKET VOLUME (UNITS)

9.3.3.2.3.3 AVERAGE SELLING PRICE (USD)

9.3.3.2.4. PALM/FOOT

9.3.3.2.4.1 MARKET VALUE (USD MILLION)

9.3.3.2.4.2 MARKET VOLUME (UNITS)

9.3.3.2.4.3 AVERAGE SELLING PRICE (USD)

9.3.3.2.5. NOSE

9.3.3.2.5.1 MARKET VALUE (USD MILLION)

9.3.3.2.5.2 MARKET VOLUME (UNITS)

9.3.3.2.5.3 AVERAGE SELLING PRICE (USD)

9.3.3.3. TABLE-TOP PULSE OXIMETER

9.3.3.3.1. MARKET VALUE (USD MILLION)

9.3.3.3.2. MARKET VOLUME (UNITS)

9.3.3.3.3. AVERAGE SELLING PRICE (USD)

9.3.3.4. OTHERS

9.3.4 PEAK FLOW METERS

9.3.4.1. DIGITAL PEAK FLOW METERS

9.3.4.1.1. PEFR

9.3.4.1.1.1 MARKET VALUE (USD MILLION)

9.3.4.1.1.2 MARKET VOLUME (UNITS)

9.3.4.1.1.3 AVERAGE SELLING PRICE (USD)

9.3.4.1.2. FORCED EXPIRATORY VOLUME (FEV1)

9.3.4.1.2.1 MARKET VALUE (USD MILLION)

9.3.4.1.2.2 MARKET VOLUME (UNITS)

9.3.4.1.2.3 AVERAGE SELLING PRICE (USD)

9.3.4.2. MECHANICAL PEAK FLOW METERS

9.3.4.2.1. MARKET VALUE (USD MILLION)

9.3.4.2.2. MARKET VOLUME (UNITS)

9.3.4.2.3. AVERAGE SELLING PRICE (USD)

9.3.5 HEART RATE MONITORS

9.3.5.1. WEARABLE

9.3.5.1.1. CHEST STRAP

9.3.5.1.1.1 MARKET VALUE (USD MILLION)

9.3.5.1.1.2 MARKET VOLUME (UNITS)

9.3.5.1.1.3 AVERAGE SELLING PRICE (USD)

9.3.5.1.2. WRIST STRAP

9.3.5.1.2.1 MARKET VALUE (USD MILLION)

9.3.5.1.2.2 MARKET VOLUME (UNITS)

9.3.5.1.2.3 AVERAGE SELLING PRICE (USD)

9.3.5.1.3. STRAPLESS

9.3.5.1.3.1 MARKET VALUE (USD MILLION)

9.3.5.1.3.2 MARKET VOLUME (UNITS)

9.3.5.1.3.3 AVERAGE SELLING PRICE (USD)

9.3.5.2. NON-WEARABLE

9.3.5.2.1. MARKET VALUE (USD MILLION)

9.3.5.2.2. MARKET VOLUME (UNITS)

9.3.5.2.3. AVERAGE SELLING PRICE (USD)

9.3.6 FETAL MONITORING DEVICES

9.3.6.1. FETAL DOPPLER

9.3.6.1.1. MARKET VALUE (USD MILLION)

9.3.6.1.2. MARKET VOLUME (UNITS)

9.3.6.1.3. AVERAGE SELLING PRICE (USD)

9.3.6.2. OTHERS

9.3.7 TEST KITS

9.3.7.1. HIV TEST KITS

9.3.7.1.1. ANTIGEN/ANTIBODY TEST

9.3.7.1.1.1 MARKET VALUE (USD MILLION)

9.3.7.1.1.2 MARKET VOLUME (UNITS)

9.3.7.1.1.3 AVERAGE SELLING PRICE (USD)

9.3.7.1.2. ANTIBODY TEST

9.3.7.1.2.1 MARKET VALUE (USD MILLION)

9.3.7.1.2.2 MARKET VOLUME (UNITS)

9.3.7.1.2.3 AVERAGE SELLING PRICE (USD)

9.3.7.1.3. OTHERS

9.3.7.2. OVULATION AND PREGNANCY TEST KITS

9.3.7.2.1. CASSETTE

9.3.7.2.1.1 URINE TEST KITS

9.3.7.2.1.1.1. MARKET VALUE (USD MILLION)

9.3.7.2.1.1.2. MARKET VOLUME (UNITS)

9.3.7.2.1.1.3. AVERAGE SELLING PRICE (USD)

9.3.7.2.1.2 BLOOD TEST KITS

9.3.7.2.1.2.1. MARKET VALUE (USD MILLION)

9.3.7.2.1.2.2. MARKET VOLUME (UNITS)

9.3.7.2.1.2.3. AVERAGE SELLING PRICE (USD)

9.3.7.2.1.3 OTHERS

9.3.7.2.2. STRIP

9.3.7.2.2.1 URINE TEST KITS

9.3.7.2.2.1.1. MARKET VALUE (USD MILLION)

9.3.7.2.2.1.2. MARKET VOLUME (UNITS)

9.3.7.2.2.1.3. AVERAGE SELLING PRICE (USD)

9.3.7.2.2.2 BLOOD TEST KITS

9.3.7.2.2.2.1. MARKET VALUE (USD MILLION)

9.3.7.2.2.2.2. MARKET VOLUME (UNITS)

9.3.7.2.2.2.3. AVERAGE SELLING PRICE (USD)

9.3.7.2.2.3 OTHERS

9.3.7.2.3. MIDSTREAM

9.3.7.2.3.1 URINE TEST KITS

9.3.7.2.3.1.1. MARKET VALUE (USD MILLION)

9.3.7.2.3.1.2. MARKET VOLUME (UNITS)

9.3.7.2.3.1.3. AVERAGE SELLING PRICE (USD)

9.3.7.2.3.2 BLOOD TEST KITS

9.3.7.2.3.2.1. MARKET VALUE (USD MILLION)

9.3.7.2.3.2.2. MARKET VOLUME (UNITS)

9.3.7.2.3.2.3. AVERAGE SELLING PRICE (USD)

9.3.7.2.3.3 OTHERS

9.3.7.2.4. TEST PANEL

9.3.7.2.4.1 URINE TEST KITS

9.3.7.2.4.1.1. MARKET VALUE (USD MILLION)

9.3.7.2.4.1.2. MARKET VOLUME (UNITS)

9.3.7.2.4.1.3. AVERAGE SELLING PRICE (USD)

9.3.7.2.4.2 BLOOD TEST KITS

9.3.7.2.4.2.1. MARKET VALUE (USD MILLION)

9.3.7.2.4.2.2. MARKET VOLUME (UNITS)

9.3.7.2.4.2.3. AVERAGE SELLING PRICE (USD)

9.3.7.2.4.3 OTHERS

9.3.7.2.5. DIPCARD

9.3.7.2.5.1 URINE TEST KITS

9.3.7.2.5.1.1. MARKET VALUE (USD MILLION)

9.3.7.2.5.1.2. MARKET VOLUME (UNITS)

9.3.7.2.5.1.3. AVERAGE SELLING PRICE (USD)

9.3.7.2.5.2 BLOOD TEST KITS

9.3.7.2.5.2.1. MARKET VALUE (USD MILLION)

9.3.7.2.5.2.2. MARKET VOLUME (UNITS)

9.3.7.2.5.2.3. AVERAGE SELLING PRICE (USD)

9.3.7.2.5.3 OTHERS

9.3.7.2.6. OTHERS

9.3.7.3. CANCER TEST KIT

9.3.7.3.1. BY TYPE

9.3.7.3.1.1 BREAST CANCER

9.3.7.3.1.1.1. MARKET VALUE (USD MILLION)

9.3.7.3.1.1.2. MARKET VOLUME (UNITS)

9.3.7.3.1.1.3. AVERAGE SELLING PRICE (USD)

9.3.7.3.1.2 PROSTATE CANCER

9.3.7.3.1.2.1. MARKET VALUE (USD MILLION)

9.3.7.3.1.2.2. MARKET VOLUME (UNITS)

9.3.7.3.1.2.3. AVERAGE SELLING PRICE (USD)

9.3.7.3.1.3 BLADDER CANCER

9.3.7.3.1.3.1. MARKET VALUE (USD MILLION)

9.3.7.3.1.3.2. MARKET VOLUME (UNITS)

9.3.7.3.1.3.3. AVERAGE SELLING PRICE (USD)

9.3.7.3.1.4 BLOOD CANCER

9.3.7.3.1.4.1. MARKET VALUE (USD MILLION)

<p class

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Testimonial
Claudio Rondena Group Business Development & Strategic Marketing Director,
C.O.C Farmaceutici SRL
"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future